SCHEMBL25820335

SCHEMBL25820335

CC(C)NS(=O)(=O)c1ccnc(C(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.46
ALDH1A1 P00352 6/20 0.44
CHRNA7 P36544 1/20 0.42
TP53 P04637 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
NAMPT P43490 1/20 0.36
PNMT P11086 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
CA9 Q16790 1/20 0.36
HTR2B P41595 1/20 0.36
ALDH3A1 P30838 1/20 0.35
KDM4E B2RXH2 1/20 0.35
KIF18A Q8NI77 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25824990 0.85 L3MBTL1 (0.46) ALDH1A1CHRNA7SMN1; SMN2CA12CA1
SCHEMBL9867987 0.81 ALDH1A1 (0.46) GFERALDH1A1TP53NPSR1KMT2A
SCHEMBL9868000 0.80 ALDH1A1 (0.51) GFERALDH1A1TP53NPSR1KMT2A
SCHEMBL5700409 0.79 CHRNA7 (0.46) CHRNA7
SCHEMBL14299655 0.77 CHRNA7 (0.58) ALDH1A1CHRNA7CA12CA1CA2
SCHEMBL9869208 0.75 ALDH1A1 (0.43) GFERALDH1A1TP53NPSR1KMT2A
SCHEMBL25825554 0.75 KMT2A (0.43) GFERALDH1A1CHRNA7TP53NPSR1
SCHEMBL20088827 0.74 NAMPT (0.55) GFERALDH1A1NPSR1KMT2AMEN1
SCHEMBL25820332 0.73 ALDH1A1 (0.37) GFERALDH1A1CHRNA7NPSR1SMN1; SMN2
SCHEMBL19935777 0.72 GFER (0.39) GFERALDH1A1TP53NPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA GFER 4727/4885ALDH1A1 3871/4885CHRNA7 4364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.